Lenacapavir, which protects people from H.I.V. infection with twice-yearly shots, is arriving in a country where the health system has been hollowed out by American aid cuts.
A Powerful H.I.V. Drug Lands in Zambia. But Will It Reach Those Who Need It?
Originally reported by New York Times. Read the full story at the original source.
Related Articles
Record daily jump in DRC Ebola outbreak takes death toll to 178
xwhatsapp-strokecopylinkgoogleAdd Al Jazeera on GoogleinfoThe coffin of an Ebola victim is carried to a gravesite in Rwa...
Former American businessman detained in Myanmar after alleged financial misconduct
Asia Former American businessman detained in Myanmar after alleged financial misconduct June 15, 20268:45 AM ET By&nb...
US and UK central banks expected to keep interest rates on hold amid Iran peace deal
Federal Reserve to make first decision under Kevin Warsh as Middle East hopes ease inflation pressuresBusiness live – la...
Backlash against ‘short-termist’ UK plans to weaken EV sales targets
Charging industry and electric vehicle manufacturers say measure could cost jobs and harm UK automotive sectorThe UK gov...